Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2007 Aug;81(2):243-51.
doi: 10.1086/519562. Epub 2007 Jun 20.

Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1

Affiliations
Case Reports

Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1

Ophélia Maertens et al. Am J Hum Genet. 2007 Aug.

Abstract

Elucidation of the biological framework underlying the development of neurofibromatosis type 1 (NF1)-related symptoms has proved to be difficult. Complicating factors include the large size of the NF1 gene, the presence of several NF1 pseudogenes, the complex interactions between cell types, and the NF1-haploinsufficient state of all cells in the body. Here, we investigate three patients with distinct NF1-associated clinical manifestations (neurofibromas only, pigmentary changes only, and association of both symptoms). For each patient, various tissues and cell types were tested with comprehensive and quantitative assays capable of detecting low-percentage NF1 mutations. This approach confirmed the biallelic NF1 inactivation in Schwann cells in neurofibromas and, for the first time, demonstrated biallelic NF1 inactivation in melanocytes in NF1-related cafe-au-lait macules. Interestingly, both disease features arise even within a background of predominantly NF1 wild-type cells. Together, the data provide molecular evidence that (1) the distinct clinical picture of the patients is due to mosaicism for the NF1 mutation and (2) the mosaic phenotype reflects the embryonic timing and, accordingly, the neural crest-derived cell type involved in the somatic NF1 mutation. The study of the affected cell types provides important insight into developmental concepts underlying particular NF1-related disease features and opens avenues for improved diagnosis and genetic counseling of individuals with mosaic NF1.

PubMed Disclaimer

Figures

Figure  1.
Figure 1.
Illustration of clinical subtypes of patients with mosaic NF1. A, Patient SNF1-2 presented with several CALMs (arrows) within a pigmented background involving the entire right leg, hip, and lower back (outlined). B, Patient SNF1-3 presented with more than six CALMs (one outlined on the left) scattered over the body and several small neurofibromas (asterisks) located on the right hand within an overlying CALM (outlined on the right).

References

Web Resources

    1. GenBank, http://www.ncbi.nlm.gov/Genbank (for NF1 [reference sequence NM_000267])
    1. Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/ (for NF1) - PubMed

References

    1. Xu GF, Lin B, Tanaka K, Dunn D, Wood D, Gesteland R, White R, Weiss R, Tamanoi F (1990) The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 63:835–84110.1016/0092-8674(90)90149-9 - DOI - PubMed
    1. Martin GA, Viskochil D, Bollag G, McCabe PC, Crosier WJ, Haubruck H, Conroy L, Clark R, O’Connell P, Cawthon RM, et al (1990) The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63:843–84910.1016/0092-8674(90)90150-D - DOI - PubMed
    1. Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, Collins F (1990) The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63:851–85910.1016/0092-8674(90)90151-4 - DOI - PubMed
    1. Riccardi VM (1992) Neurofibromatosis: phenotype, natural history and pathogenesis. John Hopkins University Press, Baltimore and London
    1. Vandenbroucke I, van Doorn R, Callens T, Cobben JM, Starink TM, Messiaen L (2004) Genetic and clinical mosaicism in a patient with neurofibromatosis type 1. Hum Genet 114:284–29010.1007/s00439-003-1047-9 - DOI - PubMed

Publication types

Associated data